Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Development of a long-acting relaxin for the treatment of pulmonary hypertension.
Journal: British journal of pharmacology
Published: August 21, 2025
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial.
Journal: British journal of clinical pharmacology
Published: June 22, 2020
First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection.
Journal: British journal of clinical pharmacology
Published: January 26, 2020
Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy.
Journal: Cardiovascular research
Published: June 15, 2018
PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab.
Journal: JACC. Basic to translational science
Published: October 01, 2016
RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm.
Journal: Kidney international
Published: May 21, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026